Hello, Fool! | Login | Signup | My Fool
Sep 7, 2008 3:32 AM ET | Site Changes | Help
The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.
View Ticker Page (BMY)
Results 21 - 30 of 132 : 12345Next »
Recs
btruemen (< 20) Submitted: 4/24/08 9:05 PM : Start Price: $22.06 BMY Score: 8.17
Old people need to stay medicated to get through the unknown...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
ottsboleego (82.32) Submitted: 4/02/08 1:37 PM : Start Price: $21.41 BMY Score: 9.40
will correct lack of products .
FGunawan (39.14) Submitted: 6/03/08 4:06 AM : Start Price: $21.69 BMY Score: 9.78
- Low valuation (P/E, P/S) compared to peers- Generous dividend yield- Management's target of 15% growth per year seems achievable- Strong growth of new products to potentially offset sales of Plavix when it goes out of patent...
willof1 (77.43) Submitted: 4/08/08 10:32 PM : Start Price: $21.58 BMY Score: 8.52
This stock is underpriced and a great value. Bristol Myers has a history of generous dividend payments. Reuters ranks this company as a bargain.
PN2LAMB (< 20) Submitted: 5/16/08 7:07 AM : Start Price: $21.70 BMY Score: 11.87
This stock will bounce back.
BILLHY13 (< 20) Submitted: 5/15/08 4:25 PM : Start Price: $21.70 BMY Score: 11.87
BMY is undervalued. Look for $28 in a few months.
goodlife1 (52.10) Submitted: 4/13/08 9:21 AM : Start Price: $21.38 BMY Score: 6.67
Simple pick. Get paid while you wait.
Smiley81 (< 20) Submitted: 5/26/08 11:22 AM : Start Price: $23.25 BMY Score: 3.61
Target: $30+
commander50 (86.81) Submitted: 4/14/08 6:47 AM : Start Price: $21.38 BMY Score: 6.67
Nice Dividend
deuspecuniae (67.62) Submitted: 5/01/08 12:11 PM : Start Price: $22.36 BMY Score: 7.00
The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical s...
Terms & Conditions
RSS Headlines
Fool UK